- Home
- CACC vs CORT Comparison
CACC vs CORT Comparison
Compare CACC & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CACC
- CORT
- Stock Information
- Founded
- CACC 1972
- CORT 1998
- Country
- CACC United States
- CORT United States
- Employees
- CACC N/A
- CORT N/A
- Industry
- CACC Finance: Consumer Services
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- CACC Finance
- CORT Health Care
- Exchange
- CACC Nasdaq
- CORT Nasdaq
- Market Cap
- CACC 6.3B
- CORT 7.5B
- IPO Year
- CACC 1992
- CORT N/A
- Fundamental
- Price
- CACC $474.74
- CORT $71.75
- Analyst Decision
- CACC Sell
- CORT Strong Buy
- Analyst Count
- CACC 2
- CORT 4
- Target Price
- CACC $475.00
- CORT $138.25
- AVG Volume (30 Days)
- CACC 106.2K
- CORT 867.7K
- Earning Date
- CACC 07-31-2025
- CORT 07-31-2025
- Dividend Yield
- CACC N/A
- CORT N/A
- EPS Growth
- CACC 143.69
- CORT N/A
- EPS
- CACC 34.75
- CORT 1.11
- Revenue
- CACC $1,173,200,000.00
- CORT $716,080,000.00
- Revenue This Year
- CACC $157.38
- CORT $35.85
- Revenue Next Year
- CACC $4.19
- CORT $35.22
- P/E Ratio
- CACC $13.66
- CORT $64.37
- Revenue Growth
- CACC 43.92
- CORT 25.71
- 52 Week Low
- CACC $409.22
- CORT $33.34
- 52 Week High
- CACC $560.00
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- CACC 44.48
- CORT 52.13
- Support Level
- CACC $461.26
- CORT $71.00
- Resistance Level
- CACC $491.60
- CORT $74.54
- Average True Range (ATR)
- CACC 13.18
- CORT 2.77
- MACD
- CACC 0.61
- CORT 0.33
- Stochastic Oscillator
- CACC 47.43
- CORT 73.01
About CACC Credit Acceptance Corporation
Credit Acceptance Corp is a consumer finance company that specializes in automobile loans. These loans are offered through a U.S. nationwide network of automobile dealers that benefit from sales of vehicles to consumers who could otherwise not obtain financing. The company also benefits from repeat and referral sales, and from sales to customers responding to advertisements for financing, but qualify for traditional financing. The company derives its revenue from finance charges, premiums earned on the reinsurance of vehicle service contracts, and other fees. Of these, financing charges, including servicing fees, are by far a source of revenue.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.